Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DB18NR
|
|||
| Drug Name |
GSK4382276A
|
|||
| Drug Type |
MRNA vaccine
|
|||
| Indication | Influenza [ICD-11: 1E30-1E32; ICD-10: J10, J11; ICD-9: 487, 488] | Phase 1 | [1] | |
| Company |
GlaxoSmithKline
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05446740) A Phase 1 Randomized, Observer-blind, Dose-escalation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of an mRNA-based Monovalent Influenza Vaccine Candidate in Healthy Younger and Older Adults. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.